TECHBio-Techne CorporationHealthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $72.33 · now $72.33 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, TECH has typically landed between $60.79 and $84.58 — a range of −16.0% to +16.9% from the issuance price $72.33.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

4,685 overlapping 1 month windows · 2008-01-02 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($72.33) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where TECH has typically landed a month from the 2026-09-16 close of $72.33 — the range is history, not a prediction.

$60.79worst · -16.0%$84.58best · +16.9%
  • now $72.33 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $71.55 (-1.1%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $66.85–$76.25
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $60.79–$84.58
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 4,685 windows spanning 2008-01-02 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2021-12-28−28.9%−28.9%+3.9%
2021-12-27−27.3%−27.3%+3.3%
2021-12-29−27.0%−29.6%+3.0%
3 best
2026-05-27+47.6%+0.0%+47.6%
2026-05-26+47.4%+0.0%+47.4%
2020-04-09+45.2%−0.9%+45.2%

4,685 overlapping windows · 2008-01-02 – 2026-09-16 · not cherry-picked

Fundamentals iCompany financials — revenue, earnings, margins — from the newest filings shown, each carried with its date.iAs-reported figures and standard ratios from FMP, as of 2026-07-25. Revenue, net income and free cash flow can toggle annual or quarterly; margin, ROE and debt-to-equity are shown by fiscal year. We report the figures and the trend — no target price and no over/under-valued call. More on /methodology.

$11.2B
market cap
$0.69
EPS (TTM)
103.8
P/E (TTM)
2026-08-05
next earnings
Revenue$1.2B
'20'25
Net income$73M
'20'25
Free cash flow$257M
'20'25
Net margin · by yr6.0%
'20'25
ROE · by yr3.8%
'20'25
Debt / equity · by yr0.23
'20'25

Fair value — three views iIndependent reference estimates of worth (a cash-flow model, peer multiples, analyst targets), shown as separate views — not a single verdict.

iThree independent estimates of per-share value, each by a different method and each with its own assumptions: a discounted-cash-flow intrinsic value, a peer comparable (the median trailing P/E of 54 sector peers times this company's trailing EPS), and the analyst price-target consensus. They routinely disagree — that gap is the point. We show the three marks and the current price; we do not blend them into a single number or call the stock over- or under-valued. Marks as of the latest capture. More on /methodology.
now $72.33$14.13$83.81
  • DCF (intrinsic)$23.00
  • Peer P/E × EPS · sector median 27.4× · n=54$18.93
  • Analyst target · range $50.00–$79.00$73.00
  • Current price · last close 2026-09-16$72.33

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~19 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
44%
−0.9%
n=18
Feb
58%
−0.0%
n=19
Mar
47%
+0.6%
n=19
Apr
58%
+1.6%
n=19
May
58%
+3.6%
n=19
Jun
58%
+3.5%
n=19
Jul
79%
+3.3%
n=19
Aug
32%
−1.9%
n=19
Sep
53%
−0.7%
n=19
Oct
44%
−1.0%
n=18
Nov
67%
+3.2%
n=18
Dec
56%
+1.5%
n=18

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$72$432026-05-08: 1 insider sale, $320K — Herr Amy E.2026-02-17: 1 insider sale, $117K — Herr Amy E.2025-08-25: 2 insider sales, $1.9M — Nusse Roeland, BAUMGARTNER ROBERT V2025-08: 2 open-market sales, $1.9M2026-02: 1 open-market sale, $117K2026-05: 1 open-market sale, $320K↑ buys↓ salesdirector Herr Amy E. — Sale on 2026-05-08, filed 4 days after the tradedirector Herr Amy E. — Sale on 2026-02-17, filed 2 days after the tradedirector Nusse Roeland — Sale on 2025-08-25, filed 2 days after the tradedirector BAUMGARTNER ROBERT V — Sale on 2025-08-25, filed 2 days after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-05-08Herr Amy E.directorSale6,636 @ $48.28$320K−97.1% of holding+12.8%not yet — horizon still open200Form 4 · filed 4 days after the trade
2026-02-17Herr Amy E.directorSale1,976 @ $59.10$117K−90.8% of holding−10.0%+10.6%200Form 4 · filed 2 days after the trade
2025-08-25Nusse RoelanddirectorSale17,040 @ $56.36$960K−27.7% of holding−12.9%−6.2%44,559Form 4 · filed 2 days after the trade
2025-08-25BAUMGARTNER ROBERT VdirectorSale17,040 @ $56.21$958K−27.5% of holding−12.9%−6.2%44,863Form 4 · filed 2 days after the trade
2025-06-09Herr Amy E.directorSale1,280 @ $49.77$64K−39.3% of holding+4.4%+6.6%1,976Form 4 · filed 2 days after the trade
2025-02-14Herr Amy E.directorSale1,860 @ $65.96$123K−48.5% of holding+3.3%−25.1%1,976Form 4 · filed 4 days after the trade
2025-01-27Kelderman KimdirectorSale11,731 @ $77.19$906K−22.4% of holding−15.2%−30.7%40,665Form 4 · filed 2 days after the trade
2025-01-27Kelderman KimdirectorSale1,661 @ $77.95$129K−4.1% of holding−15.2%−30.7%39,004Form 4 · filed 2 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

200 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-08-17Bohnen ShaneofficerAward / grant18,43218,432Form 4
2026-08-17Herr Amy E.directorAward / grant1,3811,381Form 4
2026-08-17Geist WilliamofficerAward / grant23,98523,985Form 4
2026-08-17Geist WilliamofficerAward / grant14,76214,762Form 4
2026-08-17Crouse Steven C.directorAward / grant14,14014,140Form 4
2026-08-17Crouse Steven C.directorAward / grant8,7028,702Form 4
2026-08-17Hippel JamesofficerAward / grant22,43822,438Form 4
2026-08-17Hippel JamesofficerAward / grant36,45936,459Form 4
2026-08-17Kelderman KimdirectorAward / grant57,59057,590Form 4
2026-08-17Kelderman KimdirectorAward / grant93,58293,582Form 4
2026-08-17Bohnen ShaneofficerAward / grant11,34411,344Form 4
2026-08-15Kelderman KimdirectorWithheld for tax10,82182,762Form 4
2026-08-15Hippel JamesofficerWithheld for tax4,310170,183Form 4
2026-08-15Geist WilliamofficerWithheld for tax1,97624,943Form 4
2026-08-15Crouse Steven C.directorWithheld for tax1,94710,237Form 4
2026-08-15Bohnen ShaneofficerWithheld for tax1,34310,360Form 4
2026-08-15Herr Amy E.directorWithheld for tax213576Form 4
2026-08-15Kelderman KimdirectorDisposition8,3190Form 4
2026-08-15Crouse Steven C.directorOption exercise5,42312,184Form 4
2026-08-15Kelderman KimdirectorOption exercise11,78523,569Form 4
2026-08-15Crouse Steven C.directorOption exercise1,3790Form 4
2026-08-15Crouse Steven C.directorOption exercise1,8681,869Form 4
2026-08-15Crouse Steven C.directorOption exercise2,1764,353Form 4
2026-08-15Bohnen ShaneofficerOption exercise4,35011,703Form 4
2026-08-15Bohnen ShaneofficerOption exercise490Form 4
2026-08-15Bohnen ShaneofficerDisposition12,117807Form 4
2026-08-15Bohnen ShaneofficerOption exercise3004,502Form 4
2026-08-15Bohnen ShaneofficerDisposition4,5020Form 4
2026-08-15Bohnen ShaneofficerOption exercise1,6691,669Form 4
2026-08-15Bohnen ShaneofficerOption exercise2,3324,664Form 4
2026-08-15Geist WilliamofficerOption exercise6,41626,919Form 4
2026-08-15Geist WilliamofficerOption exercise5678,507Form 4
2026-08-15Geist WilliamofficerDisposition8,5070Form 4
2026-08-15Geist WilliamofficerDisposition22,8981,526Form 4
2026-08-15Geist WilliamofficerOption exercise2,6232,623Form 4
2026-08-15Geist WilliamofficerOption exercise3,2266,452Form 4
2026-08-15Hippel JamesofficerOption exercise9,779174,493Form 4
2026-08-15Hippel JamesofficerOption exercise86612,999Form 4
2026-08-15Hippel JamesofficerDisposition12,9990Form 4
2026-08-15Hippel JamesofficerDisposition34,9822,332Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures iStock trades disclosed by members of Congress for this company, by the date they were filed.iDisclosures shown as facts. A purchase “cluster” (≥2 members of Congress filing a buy within 90 days) has historically preceded modestly higher forward returns — and it persisted out-of-sample, though it roughly halved after 2021 (see below). A descriptive historical tendency, not a signal to trade and not used in our forecast. See /methodology.

As of 2026-09-16 · point-in-time by filed date

Purchase clusters · 2015–2021 (dev)+45 bp/mo vs baseline · up-rate 59.3% vs 57.3% · n=31,607 cluster ticker-weeks
Purchase clusters · 2022–2026 (out-of-sample)+32 bp/mo vs baseline · up-rate 54.0% vs 53.3% · n=27,793

A cluster = ≥2 members of Congress filing a purchase within 90 days. The historical tilt persisted after 2021 but roughly halved (+45 → +32 bp/mo forward 1-month vs the S&P 500 weekly-grid baseline). Descriptive historical tendency — not a signal to trade, and not used in our forecast (audition-log 2026-07-27, recomputed 2026-09-08).

'23 Q'24 Q'24 Q'24 Q'24 Q'25 Q'25 Q'25 Q'25 Q'26 Q'26 Q'26 Qpurchases ▲ / sales ▼ ($ vol)
MemberChamberTypeFiledTradedSize
Ro KhannaHousesale2026-07-062026-06-02$1–15K
Ro KhannaHousesale2026-07-062026-06-30$1–15K
Ro KhannaHousepurchase2026-06-092026-05-15$1–15K
Ro KhannaHousesale2026-05-112026-04-13$1–15K
April Mcclain DelaneyHousesale2026-05-062026-04-08$1–15K
Ro KhannaHousepurchase2026-04-072026-03-30$1–15K
April Mcclain DelaneyHousesale2026-04-062026-03-26$1–15K
April Mcclain DelaneyHousesale2026-03-102026-02-24$1–15K
Ro KhannaHousepurchase2026-02-062026-01-29$1–15K
April Mcclain DelaneyHousesale2026-02-022026-01-28$1–15K
April Mcclain DelaneyHousepurchase2026-01-052025-12-05$1–15K
April Mcclain DelaneyHousepurchase2026-01-052025-12-02$1–15K
April Mcclain DelaneyHousepurchase2025-11-042025-10-22$1–15K
April Mcclain DelaneyHousesale2025-09-022025-08-01$1–15K

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.